Quadrant Capital Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Quadrant Capital Group’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-54	Closed	-$1K	–	2663
2021 Q1	$1K	Hold	54	–	–	﹤0.01%	2366
2020 Q4	$1K	Buy	+54	New	+$716	﹤0.01%	2267
2018 Q4	–	Sell	-1,500	Closed	-$11K	–	2350
2018 Q3	$11K	Hold	1,500	–	–	﹤0.01%	1262
2018 Q2	$9K	Hold	1,500	–	–	﹤0.01%	1338
2018 Q1	$8K	Buy	+1,500	New	+$7.46K	﹤0.01%	1384

Quadrant Capital Group's GNMK Position: Q2 2021 in Review

Quadrant Capital Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 54 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in GNMK in Q1 2018 and held it in 5 quarters. The position peaked at $11K in Q3 2018. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Quadrant Capital Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Quadrant Capital Group sold 54 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1K.
Quadrant Capital Group first reported a position in GenMark Diagnostics, Inc in Q1 2018 and held it in 5 quarters.
Quadrant Capital Group's GenMark Diagnostics, Inc position peaked at $11K in Q3 2018.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Quadrant Capital Group's 13F filing for Q2 2021, filed 9 Aug 2021.